0001104659-21-027293.txt : 20210224 0001104659-21-027293.hdr.sgml : 20210224 20210224114235 ACCESSION NUMBER: 0001104659-21-027293 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200215 FILED AS OF DATE: 20210224 DATE AS OF CHANGE: 20210224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leen Ann M. CENTRAL INDEX KEY: 0001763026 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37939 FILM NUMBER: 21670142 MAIL ADDRESS: STREET 1: 5 WEST FORSYTH STREET STREET 2: SUITE 200 CITY: JACKSONVILLE STATE: FL ZIP: 32202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Marker Therapeutics, Inc. CENTRAL INDEX KEY: 0001094038 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880277072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3200 SOUTHWEST FREEWAY STREET 2: SUITE 2500 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: (713) 400-6400 MAIL ADDRESS: STREET 1: 3200 SOUTHWEST FREEWAY STREET 2: SUITE 2500 CITY: HOUSTON STATE: TX ZIP: 77027 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC. DATE OF NAME CHANGE: 20170629 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC DATE OF NAME CHANGE: 20070628 FORMER COMPANY: FORMER CONFORMED NAME: GENEMAX CORP DATE OF NAME CHANGE: 20020718 4 1 tm217831d1_form4.xml FORM 4 X0306 4 2020-02-15 1 0001094038 Marker Therapeutics, Inc. MRKR 0001763026 Leen Ann M. 3200 SOUTHWEST FREEWAY, SUITE 2500 HOUSTON TX 77027 0 1 0 0 Chief Scientific Officer The reporting person resigned as Chief Scientific Officer February 15, 2021. As a result, the reporting person was no longer an officer of the Issuer and was thereafter no longer subject to Section 16 in connection with her transactions in the equity securities of the Issuer and will no longer report any such transactions on Form 4 or Form 5. /s/ Mark A. Catchur, as Attorney-in-Fact for Ann M. Leen 2021-02-24